PGEN
Price
$0.92
Change
-$0.03 (-3.16%)
Updated
Nov 13 closing price
104 days until earnings call
PTCT
Price
$44.03
Change
-$0.59 (-1.32%)
Updated
Nov 13 closing price
103 days until earnings call
Ad is loading...

PGEN vs PTCT

Header iconPGEN vs PTCT Comparison
Open Charts PGEN vs PTCTBanner chart's image
Precigen
Price$0.92
Change-$0.03 (-3.16%)
Volume$645.44K
CapitalizationN/A
PTC Therapeutics
Price$44.03
Change-$0.59 (-1.32%)
Volume$648.54K
CapitalizationN/A
PGEN vs PTCT Comparison Chart
Loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PGEN vs. PTCT commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEN is a StrongSell and PTCT is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (PGEN: $0.92 vs. PTCT: $44.05)
Brand notoriety: PGEN and PTCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PGEN: 88% vs. PTCT: 85%
Market capitalization -- PGEN: $267.97M vs. PTCT: $3.4B
PGEN [@Biotechnology] is valued at $267.97M. PTCT’s [@Biotechnology] market capitalization is $3.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PGEN’s FA Score shows that 0 FA rating(s) are green whilePTCT’s FA Score has 0 green FA rating(s).

  • PGEN’s FA Score: 0 green, 5 red.
  • PTCT’s FA Score: 0 green, 5 red.
According to our system of comparison, PTCT is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PGEN’s TA Score shows that 4 TA indicator(s) are bullish while PTCT’s TA Score has 4 bullish TA indicator(s).

  • PGEN’s TA Score: 4 bullish, 5 bearish.
  • PTCT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PTCT is a better buy in the short-term than PGEN.

Price Growth

PGEN (@Biotechnology) experienced а +2.30% price change this week, while PTCT (@Biotechnology) price change was +2.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

PGEN is expected to report earnings on Feb 26, 2025.

PTCT is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCT($3.4B) has a higher market cap than PGEN($268M). PTCT YTD gains are higher at: 59.833 vs. PGEN (-31.664). PGEN (-130.97M) and PTCT (-132.14M) have comparable annual earnings (EBITDA) . PTCT has more cash in the bank: 1.09B vs. PGEN (19.5M). PGEN has less debt than PTCT: PGEN (6.34M) vs PTCT (396M). PTCT has higher revenues than PGEN: PTCT (900M) vs PGEN (4.39M).
PGENPTCTPGEN / PTCT
Capitalization268M3.4B8%
EBITDA-130.97M-132.14M99%
Gain YTD-31.66459.833-53%
P/E RatioN/AN/A-
Revenue4.39M900M0%
Total Cash19.5M1.09B2%
Total Debt6.34M396M2%
FUNDAMENTALS RATINGS
PGEN vs PTCT: Fundamental Ratings
PGEN
PTCT
OUTLOOK RATING
1..100
139
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
98
Overvalued
PROFIT vs RISK RATING
1..100
10083
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6137
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5042

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PGEN's Valuation (61) in the null industry is somewhat better than the same rating for PTCT (98) in the Biotechnology industry. This means that PGEN’s stock grew somewhat faster than PTCT’s over the last 12 months.

PTCT's Profit vs Risk Rating (83) in the Biotechnology industry is in the same range as PGEN (100) in the null industry. This means that PTCT’s stock grew similarly to PGEN’s over the last 12 months.

PGEN's SMR Rating (97) in the null industry is in the same range as PTCT (100) in the Biotechnology industry. This means that PGEN’s stock grew similarly to PTCT’s over the last 12 months.

PTCT's Price Growth Rating (37) in the Biotechnology industry is in the same range as PGEN (61) in the null industry. This means that PTCT’s stock grew similarly to PGEN’s over the last 12 months.

PTCT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as PGEN (100) in the null industry. This means that PTCT’s stock grew similarly to PGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PGENPTCT
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Ad is loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PTCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VINAX141.350.16
+0.11%
Vanguard Industrials Index Admiral
FIZRX40.03-0.11
-0.27%
Delaware Opportunity R
RYKIX111.19-0.50
-0.45%
Rydex Banking Inv
ESPTX10.22-0.07
-0.68%
UBS International Sustainable Equity P2
ETCHX32.12-0.24
-0.74%
Eventide Healthcare & Life Sciences C

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with CRSP. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
-3.57%
CRSP - PGEN
53%
Loosely correlated
-1.85%
NTLA - PGEN
52%
Loosely correlated
-3.24%
BEAM - PGEN
51%
Loosely correlated
-1.57%
ALEC - PGEN
51%
Loosely correlated
-7.75%
DNLI - PGEN
50%
Loosely correlated
-0.84%
More

PTCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with DYN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
-1.28%
DYN - PTCT
42%
Loosely correlated
+16.40%
XNCR - PTCT
41%
Loosely correlated
-0.42%
NTLA - PTCT
40%
Loosely correlated
-3.24%
ABSI - PTCT
40%
Loosely correlated
-13.74%
PGEN - PTCT
39%
Loosely correlated
-3.57%
More